Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups-Reference-Cited by-同舟云学术

Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups

Published:2023-05-24 Issue:8 Volume:75 Page:1325-1327
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Rome Benjamin N.¹^ORCID,Kesselheim Aaron S.¹

Affiliation:

1. Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine Brigham and Women's Hospital, and Harvard Medical School Boston Massachusetts

Funder

Arnold Ventures

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.42520

Reference15 articles.

1. How a drug company made $114 billion by gaming the U.S. patent system;Robbins R.;The New York Times,2023

2. Biosimilars in the United States 2020–2024: competition, savings, and sustainability;Aitken M;IQVIA,2020

3. U.S. House of Representatives Committee on Oversight and Reform.Drug Pricing Investigation: AbbVie—Humira and Imbruvica [staff report];2021. URL:https://oversightdemocrats.house.gov/sites/democrats.oversight.house.gov/files/Committee%20on%20Oversight%20and%20Reform%20‐%20AbbVie%20Staff%20Report.pdf.

4. Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions

5. Barriers To US Biosimilar Market Growth: Lessons From Biosimilar Patent Litigation

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA;Pharmaceutical Medicine;2024-07

2. “Rounding Third Base and Heading Home”: Arthritis & Rheumatology in 2024;Arthritis & Rheumatology;2024-04-04

3. Patient Out-of-Pocket Costs for Biologic Drugs After Biosimilar Competition;JAMA Health Forum;2024-03-29

4. LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies;PLOS Computational Biology;2024-03-05